Annual Cash & Cash Equivalents
$433.50 M
-$43.47 M-9.11%
December 31, 2023
Summary
- As of February 7, 2025, ASND annual cash & cash equivalents is $433.50 million, with the most recent change of -$43.47 million (-9.11%) on December 31, 2023.
- During the last 3 years, ASND annual cash & cash equivalents has fallen by -$285.43 million (-39.70%).
- ASND annual cash & cash equivalents is now -39.70% below its all-time high of $718.93 million, reached on December 31, 2020.
Performance
ASND Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$698.64 M
+$421.34 M+151.95%
September 30, 2024
Summary
- As of February 7, 2025, ASND quarterly cash and cash equivalents is $698.64 million, with the most recent change of +$421.34 million (+151.95%) on September 30, 2024.
- Over the past year, ASND quarterly cash and cash equivalents has increased by +$231.56 million (+49.57%).
- ASND quarterly cash and cash equivalents is now -22.06% below its all-time high of $896.33 million, reached on September 30, 2020.
Performance
ASND Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
ASND Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -9.1% | +49.6% |
| 3 y3 years | -39.7% | -13.1% |
| 5 y5 years | +36.4% | -3.0% |
ASND Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -14.2% | at low | -17.2% | +151.9% |
| 5 y | 5-year | -39.7% | at low | -22.1% | +158.2% |
| alltime | all time | -39.7% | +2155.2% | -22.1% | +6861.5% |
Ascendis Pharma A/S Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $698.64 M(+151.9%) |
| Jun 2024 | - | $277.30 M(-19.8%) |
| Mar 2024 | - | $345.83 M(-20.2%) |
| Dec 2023 | $433.50 M(-9.1%) | $433.50 M(-7.2%) |
| Sep 2023 | - | $467.08 M(+9.0%) |
| Jun 2023 | - | $428.42 M(-21.6%) |
| Mar 2023 | - | $546.62 M(+14.6%) |
| Dec 2022 | $476.97 M(-5.6%) | $476.97 M(-20.2%) |
| Sep 2022 | - | $597.92 M(-14.9%) |
| Jun 2022 | - | $702.37 M(-16.7%) |
| Mar 2022 | - | $843.39 M(+66.9%) |
| Dec 2021 | $505.27 M(-29.7%) | $505.27 M(-37.1%) |
| Sep 2021 | - | $803.74 M(+75.6%) |
| Jun 2021 | - | $457.61 M(-21.1%) |
| Mar 2021 | - | $580.34 M(-19.3%) |
| Dec 2020 | $718.93 M(+7.3%) | $718.93 M(-19.8%) |
| Sep 2020 | - | $896.33 M(+231.2%) |
| Jun 2020 | - | $270.60 M(-54.1%) |
| Mar 2020 | - | $589.39 M(-12.0%) |
| Dec 2019 | $669.98 M | $669.98 M(-7.0%) |
| Sep 2019 | - | $720.64 M(-8.2%) |
| Jun 2019 | - | $784.93 M(+0.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $782.35 M(+146.1%) |
| Dec 2018 | $317.85 M(+35.6%) | $317.85 M(-11.9%) |
| Sep 2018 | - | $360.61 M(-11.5%) |
| Jun 2018 | - | $407.68 M(-5.1%) |
| Mar 2018 | - | $429.55 M(+83.3%) |
| Dec 2017 | $234.36 M(+22.9%) | $234.36 M(-3.6%) |
| Sep 2017 | - | $243.03 M(+66.9%) |
| Jun 2017 | - | $145.65 M(-13.5%) |
| Mar 2017 | - | $168.47 M(-11.6%) |
| Dec 2016 | $190.64 M(+45.7%) | $190.64 M(+128.0%) |
| Sep 2016 | - | $83.61 M(-17.2%) |
| Jun 2016 | - | $100.95 M(-12.6%) |
| Mar 2016 | - | $115.45 M(-11.7%) |
| Dec 2015 | $130.81 M(+114.4%) | $130.81 M(-9.3%) |
| Sep 2015 | - | $144.30 M(-6.7%) |
| Jun 2015 | - | $154.62 M(-7.0%) |
| Mar 2015 | - | $166.17 M(+172.4%) |
| Dec 2014 | $61.00 M(+127.4%) | $61.00 M(+507.9%) |
| Sep 2014 | - | $10.04 M(-62.6%) |
| Dec 2013 | $26.83 M(+39.6%) | $26.83 M |
| Dec 2012 | $19.22 M(-5.4%) | - |
| Dec 2011 | $20.31 M | - |
FAQ
- What is Ascendis Pharma A/S annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Ascendis Pharma A/S?
- What is Ascendis Pharma A/S annual cash & cash equivalents year-on-year change?
- What is Ascendis Pharma A/S quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Ascendis Pharma A/S?
- What is Ascendis Pharma A/S quarterly cash and cash equivalents year-on-year change?
What is Ascendis Pharma A/S annual cash & cash equivalents?
The current annual cash & cash equivalents of ASND is $433.50 M
What is the all time high annual cash & cash equivalents for Ascendis Pharma A/S?
Ascendis Pharma A/S all-time high annual cash & cash equivalents is $718.93 M
What is Ascendis Pharma A/S annual cash & cash equivalents year-on-year change?
Over the past year, ASND annual cash & cash equivalents has changed by -$43.47 M (-9.11%)
What is Ascendis Pharma A/S quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of ASND is $698.64 M
What is the all time high quarterly cash and cash equivalents for Ascendis Pharma A/S?
Ascendis Pharma A/S all-time high quarterly cash and cash equivalents is $896.33 M
What is Ascendis Pharma A/S quarterly cash and cash equivalents year-on-year change?
Over the past year, ASND quarterly cash and cash equivalents has changed by +$231.56 M (+49.57%)